---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42720235.md"
description: "$So-Young(SY.US) rose 10%, but the trading volume was only one-third of the usual – a low-volume pump, the classic script for a small-cap medical aesthetics stock.$Direxion S&P Biotech Bull 3X(LABU.US) edged up slightly, $PEGBIO CO-B(02565.HK) edged down slightly. The overall pharmaceutical sector was sluggish, with only $So-Young(SY.US) dancing alone. In the Q1 earnings report, the medical aesthetic center business grew 185% year-on-year. The story is real, but a rise without volume can easily fall back without volume at any time.How much do you believe in the recovery of light medical aesthetics? I believe half of it – the average customer spending is decreasing, customer traffic is increasing. The business is becoming more mass-market, but also thinner in terms of profit margins."
datetime: "2026-07-16T10:56:43.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42720235.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42720235.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42720235.md)
author: "[主要靠运气](https://longbridge.com/en/profiles/27426993.md)"
---

# $So-Young(SY.US) rose 10%, but the trading volume …


### Related Stocks

- [SY.US](https://longbridge.com/en/quote/SY.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [02565.HK](https://longbridge.com/en/quote/02565.HK.md)